Pfiz­er teams up with dig­i­tal ther­a­peu­tics part­ner for next prod­uct launch, this time in atopic der­mati­tis

Big Phar­ma has been slow­ly but sure­ly warm­ing up to the po­ten­tial of dig­i­tal ther­a­peu­tics, as ev­i­denced by Sanofi ink­ing a deal two months ago with Dar­i­o­Health. And on Thurs­day, an­oth­er Big Phar­ma will take a look at the space in what it deems as sim­ply the next step in an on­go­ing part­ner­ship.

Ice­landic biotech Side­kick Health an­nounced the launch of its dig­i­tal ther­a­peu­tics prod­uct specif­i­cal­ly geared for atopic der­mati­tis Thurs­day along­side Pfiz­er, its Big Phar­ma part­ner who col­lab­o­rat­ed on the in­di­ca­tion. CMO and co-founder Sae­mu­ndur “Sam” Odd­s­son told End­points News that this is not the first time that Pfiz­er and Side­kick Health have worked to­geth­er — in fact, it is the fourth dig­i­tal ther­a­peu­tics prod­uct that the pair have co-launched.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER